165 tracked 13F filers disclose a position in HTFL as of the latest SEC 13F filings, a combined $1.3B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | $247.9M | 8.4M | ▼−19% Reduced · −2.0M sh | Q2 2026 | |
| 2 | FMR LLC | $131.3M | 5.4M | ▲+31% Added · +1.3M sh | Q1 2026 | |
| 3 | JANUS HENDERSON GROUP PLC | $53.1M | 2.2M | ▲+152% Added · +1.3M sh | Q1 2026 | |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | $49.8M | 2.0M | →First observed position No prior filed position | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $46.1M | 1.9M | →First observed position No prior filed position | Q1 2026 | |
| 6 | SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $49.7M | 1.7M | ▲+90% Added · +803K sh | Q2 2026 | |
| 7 | STATE STREET CORP | $43.3M | 1.5M | ▲+225% Added · +1.0M sh | Q2 2026 | |
| 8 | BlackRock, Inc. | $35.6M | 1.5M | ▲+9.0% Added · +120K sh | Q1 2026 | |
| 9 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $34.4M | 1.4M | ▼−1.1% Reduced · −16K sh | Q1 2026 | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $39.9M | 1.4M | ▲+151% Added · +819K sh | Q2 2026 | |
| 11 | ALLIANCEBERNSTEIN L.P. | $35.7M | 1.2M | ▲+12% Added · +135K sh | Q1 2026 | |
| 12 | MILLENNIUM MANAGEMENT LLC | $26.6M | 1.1M | ▲16× Added · +1.0M sh | Q1 2026 | |
| 13 | BAILLIE GIFFORD & CO | $26.4M | 1.1M | ▼−64% Reduced · −1.9M sh | Q1 2026 | |
| 14 | 12 West Capital Management LP | $26.5M | 903K | ▲+41% Added · +263K sh | Q2 2026 | |
| 15 | MORGAN STANLEY | $20.7M | 852K | ▲+14% Added · +106K sh | Q1 2026 | |
| 16 | FRANKLIN RESOURCES INC | $19.3M | 794K | ▲+16% Added · +109K sh | Q1 2026 | |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | $18.4M | 757K | ▲+50% Added · +251K sh | Q1 2026 | |
| 18 | CITADEL ADVISORS LLC | $18.4M | 757K | ▼−39% Reduced · −492K sh | Q1 2026 | |
| 19 | Champlain Investment Partners, LLC | $21.5M | 734K | ▲+29% Added · +166K sh | Q2 2026 | |
| 20 | VOYA INVESTMENT MANAGEMENT LLC | $17.7M | 728K | ▲+218% Added · +499K sh | Q1 2026 | |
| 21 | NEXT CENTURY GROWTH INVESTORS LLC | $19.7M | 671K | ▲+2.8% Added · +18K sh | Q2 2026 | |
| 22 | FRED ALGER MANAGEMENT, LLC | $15.5M | 638K | ▲+45% Added · +198K sh | Q1 2026 | |
| 23 | XXEC, Inc. | $18.4M | 599K | ▲+115% Added · +321K sh | Q2 2026 | |
| 24 | Catalio Capital Management, LP | $17.1M | 583K | ▲+44% Added · +179K sh | Q2 2026 | |
| 25 | Rock Springs Capital Management LP | $16.8M | 574K | ▲+0.2% Added · +1K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 18 funds opened a new position in HTFL and 22 added to an existing one, while 13 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 79 funds | $238.0B |
| MICROSOFT CORPMSFT | 79 funds | $155.8B |
| AMAZON.COM INCAMZN | 79 funds | $119.8B |
| ALPHABET INC-CL AGOOGL | 77 funds | $82.3B |
| META PLATFORMS INC-CLASS AMETA | 77 funds | $68.8B |
| BROADCOM INCAVGO | 75 funds | $92.8B |
| APPLE INCAAPL | 74 funds | $168.2B |
| INTUITIVE SURGICAL INCISRG | 74 funds | $18.4B |
| ALPHABET INC-CL CGOOG | 73 funds | $79.1B |
| ELI LILLY & COLLY | 73 funds | $46.5B |
| ADVANCED MICRO DEVICESAMD | 73 funds | $19.2B |
| COSTCO WHOLESALE CORPCOST | 73 funds | $18.3B |
Ranked by how many of HTFL's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 27K | $1.4M |
| Aug 18, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 33K | $1.5M |
| Aug 17, 2026 | Rogers Campbell | Chief Medical Officer | Sell (S) | 9K | $380K |
| Aug 14, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 16K | $608K |
| Aug 10, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 23K | $639K |
| Jul 15, 2026 | Rogers Campbell | Chief Medical Officer | Sell (S) | 9K | $237K |
| Jul 10, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 23K | $626K |
| Jun 24, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 39K | $1.4M |
| Jun 10, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 23K | $643K |
| May 18, 2026 | Rogers Campbell | Chief Medical Officer | Sell (S) | 9K | $261K |
| May 11, 2026 | Farquhar John C.M. | Chief Executive Officer, Director | Sell (S) | 23K | $657K |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Sell (S) | 893K | $26.0M |
Connected entities for HTFL
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HTFL/capital-change-brief"
Use Arkolith's capital_change_brief for HTFL. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for HTFL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.